Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?
Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers hav...
Gespeichert in:
Veröffentlicht in: | Headache 2009-07, Vol.49 (7), p.1028-1041 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1041 |
---|---|
container_issue | 7 |
container_start_page | 1028 |
container_title | Headache |
container_volume | 49 |
creator | Bigal, Marcelo Krymchantowski, Abouch Valenty Lipton, Richard B. |
description | Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process. |
doi_str_mv | 10.1111/j.1526-4610.2009.01410.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67467569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67467569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4300-457078e58244697cd779891d30c30f8e7130cf65dfea71b0a910cf4e64022b9d3</originalsourceid><addsrcrecordid>eNqNkU9vEzEQxS0EomnhKyBfQBy6Yfx_9wIqbWmQElopRTlazu4sOGx2i72B5NvjJVG4Ab54PP7N85MfIZTBmKX1ZjVmiutM6tTgAMUYmEzl9hEZHS8ekxEAM1luZH5CTmNcAYDUhX5KTlgh8oIJMyL3710IHkOkfUfnrvexdmXfhR2d-S_B-Rbp7aYvuzXGMV18dT2duB9IF0in6EKL1XnqYkB61Q3Nee_a6t0z8qR2TcTnh_2MfP5wfX85yaa3Nx8vL6ZZKQVAJpUBk6PKuUy-TFkZUyRblYBSQJ2jYamqtapqdIYtwRUsnSVqCZwvi0qckVd73YfQfd9g7O3axxKbxrXYbaLVRmqjdPFPkCdBUNwk8PVfQaY0MFAKIKH5Hi1DF2PA2j4Ev3ZhZxnYISW7skMYdgjDDinZ3ynZbRp9cXhls1xj9WfwEEsCXh4AF0vX1MG1pY9HjjMjuFaDh7d77qdvcPffBuzk-uJqKJNAthfwscftUcCFb-nzhFF28enG8gLu7mazuZ2LX4kjuQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560105500</pqid></control><display><type>article</type><title>Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Bigal, Marcelo ; Krymchantowski, Abouch Valenty ; Lipton, Richard B.</creator><creatorcontrib>Bigal, Marcelo ; Krymchantowski, Abouch Valenty ; Lipton, Richard B.</creatorcontrib><description>Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process.</description><identifier>ISSN: 0017-8748</identifier><identifier>EISSN: 1526-4610</identifier><identifier>DOI: 10.1111/j.1526-4610.2009.01410.x</identifier><identifier>PMID: 19389137</identifier><identifier>CODEN: HEADAE</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>barriers to care ; Biological and medical sciences ; Cardiovascular system ; Communication Barriers ; Humans ; Medical sciences ; Migraine Disorders - psychology ; Migraine Disorders - therapy ; migraine outcomes ; Neurology ; Pharmacology. Drug treatments ; Physician-Patient Relations ; Referral and Consultation ; satisfaction ; Surveys and Questionnaires ; Treatment Outcome ; Vascular diseases and vascular malformations of the nervous system ; Vasodilator agents. Cerebral vasodilators</subject><ispartof>Headache, 2009-07, Vol.49 (7), p.1028-1041</ispartof><rights>2009 the Authors. Journal compilation © 2009 American Headache Society</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4300-457078e58244697cd779891d30c30f8e7130cf65dfea71b0a910cf4e64022b9d3</citedby><cites>FETCH-LOGICAL-c4300-457078e58244697cd779891d30c30f8e7130cf65dfea71b0a910cf4e64022b9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1526-4610.2009.01410.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1526-4610.2009.01410.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21732650$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19389137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bigal, Marcelo</creatorcontrib><creatorcontrib>Krymchantowski, Abouch Valenty</creatorcontrib><creatorcontrib>Lipton, Richard B.</creatorcontrib><title>Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?</title><title>Headache</title><addtitle>Headache</addtitle><description>Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process.</description><subject>barriers to care</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Communication Barriers</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Migraine Disorders - psychology</subject><subject>Migraine Disorders - therapy</subject><subject>migraine outcomes</subject><subject>Neurology</subject><subject>Pharmacology. Drug treatments</subject><subject>Physician-Patient Relations</subject><subject>Referral and Consultation</subject><subject>satisfaction</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><subject>Vasodilator agents. Cerebral vasodilators</subject><issn>0017-8748</issn><issn>1526-4610</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9vEzEQxS0EomnhKyBfQBy6Yfx_9wIqbWmQElopRTlazu4sOGx2i72B5NvjJVG4Ab54PP7N85MfIZTBmKX1ZjVmiutM6tTgAMUYmEzl9hEZHS8ekxEAM1luZH5CTmNcAYDUhX5KTlgh8oIJMyL3710IHkOkfUfnrvexdmXfhR2d-S_B-Rbp7aYvuzXGMV18dT2duB9IF0in6EKL1XnqYkB61Q3Nee_a6t0z8qR2TcTnh_2MfP5wfX85yaa3Nx8vL6ZZKQVAJpUBk6PKuUy-TFkZUyRblYBSQJ2jYamqtapqdIYtwRUsnSVqCZwvi0qckVd73YfQfd9g7O3axxKbxrXYbaLVRmqjdPFPkCdBUNwk8PVfQaY0MFAKIKH5Hi1DF2PA2j4Ev3ZhZxnYISW7skMYdgjDDinZ3ynZbRp9cXhls1xj9WfwEEsCXh4AF0vX1MG1pY9HjjMjuFaDh7d77qdvcPffBuzk-uJqKJNAthfwscftUcCFb-nzhFF28enG8gLu7mazuZ2LX4kjuQA</recordid><startdate>200907</startdate><enddate>200907</enddate><creator>Bigal, Marcelo</creator><creator>Krymchantowski, Abouch Valenty</creator><creator>Lipton, Richard B.</creator><general>Blackwell Publishing Inc</general><general>Wiley-Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200907</creationdate><title>Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?</title><author>Bigal, Marcelo ; Krymchantowski, Abouch Valenty ; Lipton, Richard B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4300-457078e58244697cd779891d30c30f8e7130cf65dfea71b0a910cf4e64022b9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>barriers to care</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Communication Barriers</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Migraine Disorders - psychology</topic><topic>Migraine Disorders - therapy</topic><topic>migraine outcomes</topic><topic>Neurology</topic><topic>Pharmacology. Drug treatments</topic><topic>Physician-Patient Relations</topic><topic>Referral and Consultation</topic><topic>satisfaction</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><topic>Vasodilator agents. Cerebral vasodilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bigal, Marcelo</creatorcontrib><creatorcontrib>Krymchantowski, Abouch Valenty</creatorcontrib><creatorcontrib>Lipton, Richard B.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Headache</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bigal, Marcelo</au><au>Krymchantowski, Abouch Valenty</au><au>Lipton, Richard B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?</atitle><jtitle>Headache</jtitle><addtitle>Headache</addtitle><date>2009-07</date><risdate>2009</risdate><volume>49</volume><issue>7</issue><spage>1028</spage><epage>1041</epage><pages>1028-1041</pages><issn>0017-8748</issn><eissn>1526-4610</eissn><coden>HEADAE</coden><abstract>Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>19389137</pmid><doi>10.1111/j.1526-4610.2009.01410.x</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0017-8748 |
ispartof | Headache, 2009-07, Vol.49 (7), p.1028-1041 |
issn | 0017-8748 1526-4610 |
language | eng |
recordid | cdi_proquest_miscellaneous_67467569 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | barriers to care Biological and medical sciences Cardiovascular system Communication Barriers Humans Medical sciences Migraine Disorders - psychology Migraine Disorders - therapy migraine outcomes Neurology Pharmacology. Drug treatments Physician-Patient Relations Referral and Consultation satisfaction Surveys and Questionnaires Treatment Outcome Vascular diseases and vascular malformations of the nervous system Vasodilator agents. Cerebral vasodilators |
title | Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A29%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Barriers%20to%20Satisfactory%20Migraine%20Outcomes.%20What%20Have%20We%20Learned,%20Where%20Do%20We%20Stand?&rft.jtitle=Headache&rft.au=Bigal,%20Marcelo&rft.date=2009-07&rft.volume=49&rft.issue=7&rft.spage=1028&rft.epage=1041&rft.pages=1028-1041&rft.issn=0017-8748&rft.eissn=1526-4610&rft.coden=HEADAE&rft_id=info:doi/10.1111/j.1526-4610.2009.01410.x&rft_dat=%3Cproquest_cross%3E67467569%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1560105500&rft_id=info:pmid/19389137&rfr_iscdi=true |